Standard & Poor's reports that the European pharmaceutical industry is looking to improve its new product flow in 2008. Not only do companies face the challenge of low R&D output but also increasing competition from generics as more products lose patent protection.
Business Week
Saturday 12 January 2008
Euro pharma squeezed
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment